Clinical Trial Update: Association of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and Immunotherapy

View source ↗

Summary

Clinical trial update investigating whether pembrolizumab infusion time affects efficacy in non-metastatic triple-negative breast cancer treated with neoadjuvan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Non-Metastatic Breast Carcinoma | Status: NOT_YET_RECRUITING